Cargando…

The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts

The miR-183 cluster, which is comprised of paralogous miRs-183, -96 and -182, is overexpressed in many cancers, including prostate adenocarcinoma (PCa). Prior studies showed that overexpression of individual pre-miRs-182, -96 and -183 in prostate cells decreased zinc import, which is a characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dambal, Shweta, Baumann, Bethany, McCray, Tara, Williams, LaTanya, Richards, Zachary, Deaton, Ryan, Prins, Gail S., Nonn, Larisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550464/ https://www.ncbi.nlm.nih.gov/pubmed/28794468 http://dx.doi.org/10.1038/s41598-017-07979-y

Ejemplares similares

Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids
por: Richards, Zachary, et al.
Publicado: (2019)

miR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cells
por: Mihelich, Brittany L., et al.
Publicado: (2016)

Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids
por: McCray, Tara, et al.
Publicado: (2021)

Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids
por: McCray, Tara, et al.
Publicado: (2021)

The microRNA-183 cluster: the family that plays together stays together
por: Dambal, Shweta, et al.
Publicado: (2015)

Association of High miR-182 Levels with Low-Risk Prostate Cancer
por: Baumann, Bethany, et al.
Publicado: (2019)

High levels of PIWI‐interacting RNAs are present in the small RNA landscape of prostate epithelium from vitamin D clinical trial specimens
por: Baumann, Bethany, et al.
Publicado: (2019)

Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids
por: Unno, Kenji, et al.
Publicado: (2017)

Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer
por: Ekoue, Dede N., et al.
Publicado: (2018)

GPX1 Localizes to the Nucleus in Prostate Epithelium and its Levels are not Associated with Prostate Cancer Recurrence
por: Ekoue, Dede N., et al.
Publicado: (2018)

Organoids model distinct Vitamin E effects at different stages of prostate cancer evolution
por: Njoroge, Rose N., et al.
Publicado: (2017)

Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021)

Harnessing the Utility of Ex Vivo Patient Prostate Tissue Slice Cultures
por: Perez, Lillian M., et al.
Publicado: (2022)

Keratin Profiling by Single-Cell RNA-Sequencing Identifies Human Prostate Stem Cell Lineage Hierarchy and Cancer Stem-Like Cells
por: Hu, Wen-Yang, et al.
Publicado: (2021)

Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
por: Garcia, Jason, et al.
Publicado: (2023)

Directed Differentiation of Human Embryonic Stem Cells into Prostate Organoids In Vitro and its Perturbation by Low-Dose Bisphenol A Exposure
por: Calderon-Gierszal, Esther L., et al.
Publicado: (2015)

Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans
por: Batai, Ken, et al.
Publicado: (2016)

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
por: Van Hemelryk, Annelies, et al.
Publicado: (2022)

miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
por: Williams, LaTanya V., et al.
Publicado: (2013)

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids
por: Van Hemelryk, Annelies, et al.
Publicado: (2023)

New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
por: Rago, Vittoria, et al.
Publicado: (2023)

Benign Prostatic Hyperplasia
Publicado: (2015)

Characterization of prostate cancer cell progression in zebrafish xenograft model
por: Xu, Wei, et al.
Publicado: (2017)

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
por: McNally, Christopher J, et al.
Publicado: (2020)

Appearance of tuft cells during prostate cancer progression
por: Vlajic, Katarina, et al.
Publicado: (2023)

3D printed model to assist endovascular prostate artery embolization for benign prostatic hyperplasia
por: Dalla, Shiv, et al.
Publicado: (2022)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Organoid culture systems for prostate epithelial tissue and prostate cancer tissue
por: Drost, Jarno, et al.
Publicado: (2016)

Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model
por: Sreekumar, Amritha, et al.
Publicado: (2023)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Selective Modulation of Endoplasmic Reticulum Stress Markers in Prostate Cancer Cells by a Standardized Mangosteen Fruit Extract
por: Li, Gongbo, et al.
Publicado: (2013)

Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort
por: Mihelich, Brittany L., et al.
Publicado: (2015)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Etiopathogenesis of benign prostatic hypeprlasia
por: Tang, Jie, et al.
Publicado: (2009)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer
por: Cheaito, Katia, et al.
Publicado: (2022)

Application of Organoid Models in Prostate Cancer Research
por: Zhou, Ligui, et al.
Publicado: (2021)

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
por: Kumar, Binod, et al.
Publicado: (2018)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v3mai1im15o5k1jviker2b2bo3